3 rd Announcement - 2011 International Conference on Diabetes ...

Scientific program
Friday 11 NOV. (7:00~8:00)
Breakfast symposium 1 Sponsored by Daewoong
Back to the fundamentals: MOA, PK, and PD of DPP-4 inhibitors
Chair : Jae Myung Yu
Young Min Cho (Seoul National University, Korea)
Breakfast symposium 2 Sponsored by Novartis
Chair : Moon Kyu Lee
Importance and management of glucose fluctuations with vildagliptin
Giuseppe Paolisso (Second University of Naples, Italy)
Beneficial impact of direct renin inhibition on renal and ca<strong>rd</strong>iovascular disease
Hans-Henrik Parving (University of Copehagen, Denmark)
Satu<strong>rd</strong>ay 12 NOV. (7:00~8:00)
Breakfast symposium 3 Sponsored by Pfizer
Chair : Dong Seop Choi
What’s new & controversy on statin treatment in diabetes
Chang Beom Lee (Hanyang University, Korea)
Breakfast symposium 4 Sponsored by MSD
Chair : Yong Ki Kim
TBA
Jeong Hyun Park (Inje University, Korea)
Friday 11 NOV. (12:00~13:30)
Luncheon symposium 1 Sponsored by AstraZeneca
Chair : Hyun Chul Lee
Overcoming barriers now in successful management of type 2 diabetes
Eun Seok Kang (Yonsei University, Korea)
Luncheon symposium 2 Sponsored by Sanofi-aventis
Chair : Sun Woo Kim
Recent issues on hypertension management and role of aprovel
Dae Jung Kim (Ajou University, Korea)
Satu<strong>rd</strong>ay 12 NOV. (12:20~14:00)
Luncheon symposium 3 Sponsored by Handok
What is your choice for glycemic control proven or new
Chair : TBA
Sin Gon Kim (Korea University, Korea)
Luncheon symposium 4 Sponsored by Abbott
Chair : TBA
The treatment of atherogenic dyslipidemia in patients with diabetes mellitus
Giuseppe M.C. Rosano (IRCCS San Raffaele, Italy)